July was a positive month for psychedelic investors with the market showing signs of price growth. Individual stocks such as Compass Pathways (CMPS), Relmada Therapeutics (RLMD), and Seelos Therapeutics (SEEL) were up 38.33%, 34.75%, and 29.56% respectively in the month. The overall positive performance in the psychedelic sector led to Psychedelic Invest’s Index being up…